MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.12

Change

-0.36 (-1.35)%

Market Cap

N/A

Volume

700.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+2.32 (+4.37%)

USD 53.00B
QQQM Invesco NASDAQ 100 ETF

-0.40 (-0.19%)

USD 38.88B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.10 (-0.18%)

USD 20.37B
ACWI iShares MSCI ACWI ETF

-0.23 (-0.20%)

USD 19.56B
CGABL The Carlyle Group Inc. 4.625% ..

+0.46 (+2.58%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+3.91 (+5.89%)

USD 5.35B
TSLL Direxion Shares ETF Trust - Di..

-3.34 (-12.13%)

USD 5.32B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 4.54B
ETHA iShares Ethereum Trust ETF

+0.91 (+3.60%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

-0.20 (-0.28%)

USD 2.29B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.48% 21% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.48% 19% F 41% F
Trailing 12 Months  
Capital Gain -6.48% 21% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.48% 19% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.48% 44% F 40% F
Dividend Return 0.48% 36% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.50% 93% A 99% N/A
Risk Adjusted Return 19.41% 43% F 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector